Inventor · disambiguated record
Angela Dawn Glendenning
Also filed as: GLENDENNING ANGELA DAWN
1 granted patent·2 pending applications·1 citations·filing 2022–2023
17Inventor score
Files withPERFUSE THERAPEUTICS INC3
Top patents by PatentIndex Score
3 records- 0182US11786510B2Pharmaceutical compositions and intravitreal drug delivery systems for the treatment of ocular diseasesPERFUSE THERAPEUTICS INC·Filed 2022·Granted Oct 17, 2023·1 cites·4 claims
- 0264US2023414577A1Pharmaceutical compositions and intravitreal drug delivery systems for the treatment of ocular diseasesPERFUSE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0353US2024058265A1Treatment of ocular diseases using endothelin receptor antagonistsPERFUSE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Angela Dawn Glendenning files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →